The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) represents an increasing cause of liver disease worldwide, mirroring the epidemics of obesity and metabolic syndrome. As there are still no licensed medications for treating the disease, there is an ongoing effort to elucidate the pathophysiology and to disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlano, Roberta, Mullish, Benjamin H., Roberts, Lauren A., Thursz, Mark R., Manousou, Pinelopi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775587/
https://www.ncbi.nlm.nih.gov/pubmed/35054847
http://dx.doi.org/10.3390/ijms23020662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775587/
https://www.ncbi.nlm.nih.gov/pubmed/35054847
http://dx.doi.org/10.3390/ijms23020662

Ejemplares similares